Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 107

Results For "health"

5527 News Found

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
Drug Approval | June 11, 2026

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules

Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.


AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Drug Approval | June 11, 2026

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer


Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio


Ten years on, PMSMA continues to shape safer motherhood in India
Policy | June 10, 2026

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities


Remidio secures Gates Foundation grant to advance AI-powered retinal screening
Healthcare | June 10, 2026

Remidio secures Gates Foundation grant to advance AI-powered retinal screening

Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities


Cipla elevates Manoj Dimri as Group Business Head
People | June 10, 2026

Cipla elevates Manoj Dimri as Group Business Head

Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


Oval Fertility and Merck India partner to advance access to high-quality fertility care
Healthcare | June 10, 2026

Oval Fertility and Merck India partner to advance access to high-quality fertility care

Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care